Data availability
Data will be shared in anonymous form on a reasoned request to the corresponding author.
References
Leonardi L, Vanoli F, Fionda L, Loreti S, Garibaldi M, Morino S, Salvetti M, Russo D, Musumeci B, Antonini G (2020) Nerve ultrasonography findings as possible pitfall in differential diagnosis between hereditary transthyretin amyloidosis with polyneuropathy and chronic inflammatory demyelinating polyneuropathy. Neurol Sci 41(Sep 16):3775–3778. https://doi.org/10.1007/s10072-020-04717-7
Padua L, Granata G, Sabatelli M, Inghilleri M, Lucchetta M, Luigetti M, Coraci D, Martinoli C, Briani C (2014) Heterogeneity of root and nerve ultrasound pattern in CIDP patients. Clin Neurophysiol 125(1):160–165. https://doi.org/10.1016/j.clinph.2013.07.023
Cortese A, Vegezzi E, Lozza A, Alfonsi E, Montini A, Moglia A, Merlini G, Obici L (2017) Diagnostic challenges in hereditary transthyretin amyloidosis with polyneuropathy: avoiding misdiagnosis of a treatable hereditary neuropathy. J Neurol Neurosurg Psychiatry 88:457–458
Lozeron P, Mariani LL, Dodet P, Beaudonnet G, Théaudin M, Adam C, Arnulf B, Adams D (2018) Transthyretin amyloid polyneuropathies mimicking a demyelinating polyneuropathy. Neurology. 91(2):e143–e152
Salvalaggio A, Coraci D, Cacciavillani M, Obici L, Mazzeo A, Luigetti M, Pastorelli F, Grandis M, Cavallaro T, Bisogni G, Lozza A, Gemelli C, Gentile L, Ermani M, Fabrizi GM, Plasmati R, Campagnolo M, Castellani F, Gasparotti R, Martinoli C, Padua L, Briani C (2020) Nerve ultrasound in hereditary transthyretin amyloidosis: red flags and possible progression biomarkers. J Neurol. Aug 4. https://doi.org/10.1007/s00415-020-10127-8
Funding
The present study was supported by an Investigator-Initiated Research to University of Padova from Pfizer Inc. Pfizer Inc. had no role in the study design, data analysis, and results interpretation of the present study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
Alessandro Salvalaggio reports travel grants from Alnylam, Akcea and Pfizer and Speaker honoraria from Alnylam; Chiara Briani reports speaker and consulting honoraria from Akcea, Alnylam and Pfizer, and travel grants from Kedrion, Alnylam, and CSL Behring.
Ethics approval
The study was approved by the “Comitato Etico per la Sperimentazione Clinica della Provincia di Padova” and by local ethical committees of all the involved centres.
Consent to participate
Enrolled subjects gave written informed consent to participate to the study.
Consent for publication
All the authors have read and approved the manuscript for publication.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Salvalaggio, A., Coraci, D., Cacciavillani, M. et al. Nerve ultrasonography features in hereditary transthyretin amyloidosis with V30M mutation and polyneuropathy. Neurol Sci 42, 2547–2548 (2021). https://doi.org/10.1007/s10072-020-05033-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-020-05033-w